Global PNH & aHUS Market: Industry Analysis & Outlook (2017-2021)

1
Industry Research by Koncept Analytics
Global PNH aHUS Market Industry Analysis
Outlook -----------------------------------------
(2017-2021)
October 2017
2
Executive Summary


PNH and aHUS, both are extremely rare and genetic
diseases. Due to PNH, destruction of red blood
cells of a person occur quite sooner than it
should. It is an acquired hematopoietic stem cell
disorder. Hematopoietic stem cells are developed
in bone marrow and eventually turn into red blood
cells, white blood cells and platelets. A person
with PNH has some defected hematopoietic cells
which create defective red blood cells. These
defective cells are highly susceptible to
premature destruction by the complement system.
aHUS is a disorders in which blood clots are
formed in small blood vessels throughout the
body. TMA can lead to heart stroke, attack,
kidney failure and death. Soliris is the only
drug treatment available in the market for
treating these diseases. Regionally, Europe held
the largest share in the global PNH drug market
and the U.S. dominated the global aHUS drug
market, supported by favorable reimbursement
policies In terms of patient population,
Asia-pacific region had the highest number of PNH
and aHUS patients. With the increasing
technological advancements in diagnosis
techniques of PNH and aHUS, the number of
diagnosed patients is likely to grow
globally. The global PNH and aHUS market is
expected to grow in future due to prolonged
orphan drug market exclusivity, attractive orphan
drug policies, increasing pharmaceutical RD
expenditure, rising health care expenditure. Key
trends of this market includes progressing drugs
under pipeline, increasing prevalence of blood
and bone marrow related disorders and favorable
reimbursement policies. However, there are some
factors which can hinder the market growth
including high costs of drugs and associated
risks. The report Global PNH and aHUS Market
Industry Analysis Outlook (2017-2021) by
Koncept Analytics provides an extensive research
and detailed analysis of the present market along
with future outlook. The report discusses the
major growth drivers and challenges of the
market, covering the U.S., Europe and
Asia-Pacific region along with the global market.
The report profiles the key players of the market
including Alexion Pharmaceuticals Inc., Alnylam
Pharmaceuticals Inc, Omeros Corporation and RA
Pharmaceuticals.
3
Increasing prevalence of blood and bone marrow
related disorders is expected to boost the global
PNH patient population
Global PNH Patient Population Forecast (2016-2021)

• Global PNH patient population is expected to
  reach ..thousand in the year 2021, increasing
  from ..thousand in the year 2016 at a CAGR of
  .. for period spanning 2016-2021.
• In the year 2021, global PNH drug market value is
  expected to reach US.. million, increasing from
  US.. million in 2016, growing at a CAGR of ..
  for period spanning 2016-2021.
• In 2016, Europe held the largest share of .. in
  global PNH drug market, followed by the U.S. with
  a share of ...

Global PNH Drug Market Value by Region (2016)
Global PNH Drug Market Value Forecast (2016-2021)
4
Global aHUS market is likely to grow with
increasing technological advancements in
diagnosis methods and rising investments in
research and development of aHUS drugs..
Global aHUS Patient Population Forecast
(2016-2021)

• Global aHUS patient population is expected to
  reach thousand in the year 2021, increasing from
  ..thousand in the year 2016 at a CAGR of .. for
  period 2016-2021..
• In the year 2021, global aHUS drug market value
  is predicted to reach US.. million, increasing
  from US.. million in 2016, recording growth at a
  CAGR of .. for period 2016-2021.
• The U.S. held the largest share of .. in the
  global aHUS drug market, followed by Europe with
  a share of .. in 2016.

Global aHUS Drug Market Value by Region (2016)
Global aHUS Drug Market Value Forecast (2016-2021)
5
For Report Purchase Click Belowhttp//www.koncep
tanalytics.com/Researchreport/global-pnh-ahus-mark
et-industry-analysis-outlook-2017-2021-26464.aspx
Disclaimer
Contact Us
This is a licensed product of Koncept Analytics.
You cannot reproduce, publish, distribute,
publicly display, sell or create other works from
this report or use them in any way for commercial
purpose without our prior permission. Further,
you cannot copy this material, by any means
(including electronic copies), for distribution
to others unless you have purchased the corporate
license of this report. We believe the sources
are reliable, but Koncept Analytics does not
warranty the accuracy or completeness of the
data. The data presented in the report is updated
at the publication date but is subject to change
at subsequent releases. All possible efforts have
been made to ensure accuracy of data. However,
investors should not completely rely on the
information given in this report and must make
decisions based on their own investment strategy,
risk management and capital adequacy.
Koncept Analytics CS-36, First Floor, Ansal
Plaza Vaishali, Ghaziabad, U.P. 201010 T
91-120-4130959 M 91-9871694789vikas_at_konceptana
lytics.com
www.konceptanalytics.com